A pharmaceutically acceptable salt of macrocyclic quinoxaline compound as an HCV NS3 protease inhibitor
PK201200412A0Undetermined Publication Date: 2012-07-25MERCK SHARP & DOHME CORP
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201200412
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2012-06-26
- Publication Date
- 2012-07-25
Need to check novelty before this filing date? Find Prior Art
No text content released.